Burning Rock Biotech Ltd (BNR) income statement
BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.32+0.25 (+1.91%)
Close on Nov 19, 2026Market cap $145.00MP/E –Yield –
Burning Rock Biotech Ltd income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 74.7%
- Operating margin
- -10.2%
- Net margin
- -10.3%
- Return on equity, FY2025
- -9.9%
Financial strength
- Current ratio
- 2.99
- Debt to equity
- 0.00
- Debt to assets
- 0.2%
- Cash to current liabilities
- 193.7%
Valuation
- P/E ratio
- –
- Price to sales
- 1.79
- Price to book
- 1.81
- Dividend yield
- –
See a number that looks wrong?